Drug Trial Radar · NCT02733185
Trial to Assess Chelation Therapy 2
Last checked: Nov 19, 2026Latest source record: Mar 30, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,000
Actual
Start
Oct 1, 2016
Primary completion
Jun 30, 2023
Study completion Jun 30, 2023
Sponsor
- Lead sponsor
- Mt. Sinai Medical Center, MiamiAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Center for Complementary and Integrative Health (NCCIH); National Heart, Lung, and Blood Institute (NHLBI); Duke Clinical Research Institute
- First posted
- Apr 11, 2016
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Factorial
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 50 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Trial to Assess Chelation Therapy 2 (TACT2) is a randomized, double blind controlled factorial clinical trial of edetate disodium-based chelation and high-dose oral vitamins and minerals to prevent recurrent cardiac events in diabetic patients with a prior myocardial infarction (MI).
Conditions
- Diabetes
- Myocardial Infarction
Interventions
disodium EDTADrug
IV Disodium Ethylene diamine tetra acetic acid in 500 cc
Oral Multi Vitamins/Minerals (OMVM)Dietary supplement
6 tablets of Multi-vitamin/Multimineral daily
Placebo disodium EDTADrug
IV Placebo comparator- 500 normal saline
Placebo Oral Multi Vitamins/Minerals (OMVM)Dietary supplement
6 tablets of a placebo Multi-vitamin/Multimineral daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Primary Composite OutcomeTime frame: 48 month follow-up (median)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Mount Sinai Medical Center
Miami Beach, Florida
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.